Reporting Owner Activity for Robert Azelby

Form 3/4/5 issuer positions and transaction evidence for this reporting owner.

Linked issuers

7

Largest position

CARDINAL HEALTH INC

Disclosed value

$929K

Transaction activity

Available

Ownership signals 1 signal
Forms 3/4/5 position snapshot

Estimated Forms 3/4/5 value

$929K

Estimated from Forms 3/4/5 when filings include enough holding data.

Issuers linked to this owner

7

Distinct issuers connected to this reporting owner in parsed SEC filings.

Latest parsed owner filing

05 May 2026

Most recent owner-level filing date in the parsed SEC record.

+5 more

Additional issuer positions are listed below.

How to read Forms 3/4/5 positions
  • Reported values are estimates from parsed SEC Forms 3/4/5 when the filing includes enough price and share data.
  • Use this as a filing-backed owner snapshot, not as a live cap table.
Identity 1 identity field
Location
Dublin, OH
SEC source record 1 source field
Latest reporting-owner signature
/s/ David Strauss, as Attorney-in-Fact for Robert Azelby
Source evidence 1 source field
SEC filing history
Open SEC filing history

Follow Filing Activity

Follow Robert Azelby and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Reported issuer positions for Robert Azelby

CAH Forms 3/4/5

CARDINAL HEALTH INC

Relationship
Director
Holdings value
$641,181
Past year net change
Change %
Report period
05 Nov 2025
ADCT Forms 3/4/5

ADC Therapeutics SA

Relationship
Director
Holdings value
$287,849
Past year net change
Change %
Report period
13 Jun 2025

Recent insider transactions for Robert Azelby

Sym Company Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .